Search Results - Serikoff, Alexis

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE

    A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE by Payne, Heather, Robinson, Angus, Rappe, Bernard, Hilman, Serena, De Giorgi, Ugo, Joniau, Steven, Bordonaro, Roberto, Mallick, Stéphane, Dourthe, Louis‐Marie, Flores, Moisés Mira, Gumà, Josep, Baron, Benoit, Duran, Aurea, Pranzo, Alessandra, Serikoff, Alexis, Mott, David, Herdman, Mike, Pavesi, Marco, De Santis, Maria

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial

    Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial by Russell, Stuart D., Selaru, Paulina, Pyne, David A., Ghazzi, Maha M., Massey, Kenneth D., Pressler, Milton, Serikoff, Alexis, Coats, Andrew J.S.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Permixon ® [Lipiod-sterolic extract of serenoa repens (LSESr)] Inhibits estrogen/androgen-induced prostate enlargment in the rat

    Permixon ® [Lipiod-sterolic extract of serenoa repens (LSESr)] Inhibits estrogen/androgen-induced prostate enlargment in the rat by Paubert-Braquet, Monique, Servent, Nathalie, Serikoff, Alexis, Raynaud, Jean-Pierre, Bazan, Nicolas G.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: